Ziopharm Oncology is focused on advancing the next generation of immunotherapies to weaponize the existing immune system with Controlled IL-12 or introduce new immune system elements with Sleeping Beauty-modified T cells to this fight against cancer. In addition to developing the next generation of immuno-oncology medicines that target multiple types of cancers, we also are targeting the cost and complexity of delivering gene and cell therapies.
Events & Presentations
Nov 20, 2019 1:20 PM GMT
Jefferies London Healthcare Conference
Nov 7, 2019 4:30 PM EST
Ziopharm Third Quarter 2019 Earnings Call
Sep 9, 2019 4:15 PM EDT
Morgan Stanley 17th Annual Global Healthcare Conference